MX2015013414A - N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa. - Google Patents
N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa.Info
- Publication number
- MX2015013414A MX2015013414A MX2015013414A MX2015013414A MX2015013414A MX 2015013414 A MX2015013414 A MX 2015013414A MX 2015013414 A MX2015013414 A MX 2015013414A MX 2015013414 A MX2015013414 A MX 2015013414A MX 2015013414 A MX2015013414 A MX 2015013414A
- Authority
- MX
- Mexico
- Prior art keywords
- kinase inhibitors
- janus kinase
- pyridones
- pyrazolo
- heterocyclyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
La presente solicitud proporciona compuestos de fórmula I, un inhibidor de JAK y el uso de los mismos para el tratamiento de enfermedades mediadas por JAK.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361803226P | 2013-03-19 | 2013-03-19 | |
PCT/CN2014/000298 WO2014146492A1 (en) | 2013-03-19 | 2014-03-19 | N-(2-cyano heterocyclyl)pyrazolo pyridones as janus kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015013414A true MX2015013414A (es) | 2016-02-26 |
Family
ID=51579321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015013414A MX2015013414A (es) | 2013-03-19 | 2014-03-19 | N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9957265B2 (es) |
EP (1) | EP2976338B1 (es) |
JP (1) | JP6322275B2 (es) |
KR (1) | KR20150130311A (es) |
CN (1) | CN105189497B (es) |
AU (1) | AU2014234908B2 (es) |
BR (1) | BR112015023878A2 (es) |
CA (1) | CA2901766A1 (es) |
MX (1) | MX2015013414A (es) |
RU (1) | RU2669922C2 (es) |
WO (1) | WO2014146492A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014146246A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
WO2016061751A1 (en) * | 2014-10-22 | 2016-04-28 | Merck Sharp & Dohme Corp. | Ethyl n-boc piperidinyl pyrazolo pyridones as janus kinase inhibitors |
EP3554499B1 (en) * | 2016-12-14 | 2022-01-26 | Merck Sharp & Dohme Corp. | Aminopyrazoles as janus kinase inhibitors |
CN114364798A (zh) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | 用于治疗癌症的Dbait分子与激酶抑制剂的组合 |
AU2020378630A1 (en) | 2019-11-08 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
CN111499592B (zh) * | 2020-03-14 | 2023-06-23 | 江苏省农用激素工程技术研究中心有限公司 | 5-氨甲基糖精的合成方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2759227B2 (ja) | 1990-09-28 | 1998-05-28 | 大鵬薬品工業株式会社 | ピラゾロピリジン誘導体 |
CA2375734A1 (en) | 1999-06-03 | 2000-12-14 | Knoll Gmbh | Benzothiazinone and benzoxazinone compounds |
JP2005525358A (ja) | 2002-02-28 | 2005-08-25 | ビオタ インコーポレーティッド | ヌクレオチド模倣体およびそのプロドラッグ |
AU2003241925A1 (en) | 2002-05-31 | 2003-12-19 | Eisai R&D Management Co., Ltd. | Pyrazole compound and medicinal composition containing the same |
JP4139185B2 (ja) | 2002-10-17 | 2008-08-27 | 京セラ株式会社 | 配線基板の製造方法 |
CA2636189A1 (en) * | 2006-01-17 | 2007-07-26 | Vertex Pharmaceuticals Incorporated | Azaindoles useful as inhibitors of janus kinases |
MX2009007426A (es) * | 2007-01-12 | 2009-07-17 | Astellas Pharma Inc | Compuesto de piridina condensado. |
JP5690823B2 (ja) | 2009-07-08 | 2015-03-25 | レオ ファーマ アクティーゼルスカブ | Jak受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物 |
CN102985417B (zh) | 2010-03-10 | 2015-01-28 | 因塞特公司 | 作为jak1抑制剂的哌啶-4-基氮杂环丁烷衍生物 |
BR112013024267A2 (pt) | 2011-03-22 | 2018-06-26 | Advinus Therapeutics Ltd | compostos tricíclicos fundidos substituídos, composições e aplicações medicinais dos mesmos. |
CA2849357A1 (en) * | 2011-09-22 | 2013-03-28 | Merck Sharp & Dohme Corp. | Acyclic cyanoethylpyrazoles as janus kinase inhibitors |
EP2857400A4 (en) * | 2012-06-01 | 2015-12-09 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUND |
WO2014146246A1 (en) * | 2013-03-19 | 2014-09-25 | Merck Sharp & Dohme Corp. | Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors |
-
2014
- 2014-03-19 KR KR1020157025519A patent/KR20150130311A/ko not_active Application Discontinuation
- 2014-03-19 CA CA2901766A patent/CA2901766A1/en not_active Abandoned
- 2014-03-19 BR BR112015023878A patent/BR112015023878A2/pt not_active Application Discontinuation
- 2014-03-19 MX MX2015013414A patent/MX2015013414A/es unknown
- 2014-03-19 EP EP14767458.4A patent/EP2976338B1/en active Active
- 2014-03-19 US US14/778,052 patent/US9957265B2/en active Active
- 2014-03-19 JP JP2016503522A patent/JP6322275B2/ja active Active
- 2014-03-19 RU RU2015144483A patent/RU2669922C2/ru not_active IP Right Cessation
- 2014-03-19 WO PCT/CN2014/000298 patent/WO2014146492A1/en active Application Filing
- 2014-03-19 AU AU2014234908A patent/AU2014234908B2/en not_active Ceased
- 2014-03-19 CN CN201480016754.4A patent/CN105189497B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2976338A4 (en) | 2016-08-31 |
AU2014234908A1 (en) | 2015-08-13 |
EP2976338A1 (en) | 2016-01-27 |
US9957265B2 (en) | 2018-05-01 |
JP2016514710A (ja) | 2016-05-23 |
BR112015023878A2 (pt) | 2017-07-18 |
US20160272633A1 (en) | 2016-09-22 |
RU2669922C2 (ru) | 2018-10-17 |
WO2014146492A1 (en) | 2014-09-25 |
CN105189497B (zh) | 2019-05-03 |
JP6322275B2 (ja) | 2018-05-09 |
CA2901766A1 (en) | 2014-09-25 |
AU2014234908B2 (en) | 2017-08-17 |
CN105189497A (zh) | 2015-12-23 |
EP2976338B1 (en) | 2018-01-03 |
KR20150130311A (ko) | 2015-11-23 |
RU2015144483A (ru) | 2017-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019501321A1 (en) | Methods of treating or preventing cholesterol related disorders | |
PH12017502090A1 (en) | Heterocyclic amides as kinase inhibitors | |
PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
PH12016500676A1 (en) | Pyrimidine fgfr4 inhibitors | |
MD20170016A2 (ro) | Compuşi aminopirimidinici ca inhibitori JAK | |
MY188447A (en) | Indazole compounds as fger kinase inhibitor, preparation and use thereof | |
PH12015500064A1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
PH12017500416A1 (en) | Compounds and compositions as raf kinase inhibitors | |
MX2015013414A (es) | N-(2-ciano heterociclil)pirazolo piridonas como inhibidores de janus quinasa. | |
MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
TW201613864A (en) | Novel compounds | |
GB201209587D0 (en) | Therapeutic compounds | |
MX2015013418A (es) | Cicloalquil nitrilo pirazolo piridonas como inhibidores de janus quinasa. | |
PH12016500347A1 (en) | Triazolopyridine compounds, compositions and methods of use thereof | |
PH12015501038A1 (en) | Inhibitors of iap | |
MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
PH12014501979A1 (en) | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor | |
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
MX2015009678A (es) | Compuestos de pirimidina condensada sustituida con amino en la posicion 4 como inhibidores de fosfodiesterasa 4 (pde4). |